A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Citation
Price , D , Asukai , Y , Ananthapavan , J , Malcolm , B , Radwan , A & Keyzor , I 2013 , ' A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use ' , Applied Health Economics and Health Policy , vol. 11 , no. 3 , pp. 259-274 . https://doi.org/10.1007/s40258-013-0021-5
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/